🟢 Eupraxia Pharmaceuticals is trading 8% up today as Healthcare gains 1.37%

Eupraxia Pharmaceuticals is trading 8.04% up at $6.85, with the move appearing supported by broader healthcare-sector strength; no clear company-specific announcement was identified for September 2, 2026.

• Healthcare is up 1.37%, supporting the move.
• Latest disclosed updates were its August 11, 2026 second-quarter results and August 13, 2026 RESOLVE trial data.